Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Shares Issued (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Shares Issued for 2 consecutive years, with -$487000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Shares Issued changed N/A to -$487000.0 in Q3 2025 year-over-year; TTM through Jun 2025 was $487000.0, a 387.0% increase, with the full-year FY2023 number at $100000.0, changed N/A from a year prior.
  • Shares Issued was -$487000.0 for Q3 2025 at Mereo BioPharma, down from $487000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $11.6 million in Q3 2023 to a low of -$11.5 million in Q4 2023.